Biotech

All Articles

ProKidney halts stage 3 test certainly not needed for tissue treatment permission

.ProKidney has quit among a pair of stage 3 trials for its cell treatment for renal condition after ...

Vaxcyte rises on 'spectacular' 31-valent PCV succeed versus Pfizer

.Vaxcyte unveiled what experts called "magnificent" phase 1/2 records for its 31-valent pneumococcal...

Recursion's brain health condition trial presents scant evidence of effectiveness

.Recursion has discovered with a very early test of its own tech-enabled strategy to drug discovery,...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Call it a situation of great chemical make up: Acepodia, a biotech based upon Nobel Prize-winning s...

Praxis epilepsy medication reduces seizures in phase 2 hearing

.Praxis Preciseness Medicines has racked up another midphase win in epilepsy this year, with its sod...

Three officers resign as Dyne posts blended records for DMD candidate

.After running away a professional grip numerous years back, Dyne Therapy has shown new phase 1/2 in...

Arrowhead fires off stage 3 data in uncommon metabolic disease before market encounter Ionis

.Arrowhead Pharmaceuticals has presented its give in front of a prospective face-off with Ionis, pub...

Pfizer, Valneva present lyme health condition try successful for second booster

.Pfizer and Valneva might possess regarding pair of more years to stand by prior to they create the ...

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Permit's dive into a conversation with Ayla Ellison, Strong Biotech Managing Editor and also Michel...

New records demonstrate how Bayer's asundexian fell short to prevent strokes

.Bayer put on hold the stage 3 test for its aspect XIa inhibitor asundexian late in 2015 after the m...